Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management
Clinical trial NCT04668170 · COMPLETED
Trial details
- NCT number
- NCT04668170
- Sponsor
- University Hospital, Toulouse
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-05-05
- Primary completion
- 2021-12-31
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.